The project aims to ensure food-security throughout the entire year in a rural district by storing food through an innovative technology known as the Solar Conduction Dryer. It also aims to add extra income to women farmers from the sale of the dehydrated products of this technology, while providing valuable lessons in post-harvest losses.

Saiqa Mullick of Wits Reproductive Health & HIV Research Institute (RHI) in South Africa, along with Grass Root Soccer (GRS), Sonke Gender Justice, and the Population Council, will empower adolescent girls in South African townships as they progress in education by increasing their educational, health, social, and economic assets, while at the same time shifting gender attitudes and encouraging positive behavior among adolescent boys. The “Girls Achieve Power” (GAP) Year Program will work with schools and communities to encourage a culture of health and safety, and promote school retention among adolescent girls. Using soccer as a program platform, and enlisting local coaches as facilitators, the program will enable a healthy and productive progression for adolescent girls through secondary school. Aside from these direct benefits, the program will also expand the evidence base around the impact of asset-building approaches for adolescent girls.

Rakesh Jain of Massachusetts General Hospital in the U.S. will develop a new treatment strategy for tuberculosis to boost the activity of existing anti-tuberculosis drugs. Tuberculosis is one of the most infectious diseases in the world. Current treatments are lengthy poorly tolerated and do not eradicate latent infections which are found in around one third of the general population and contribute to drug resistance. During latent infection the tuberculosis bacteria are dormant and reside in small inflammatory areas in the lungs known as granulomas. These granulomas are surrounded by abnormal blood vessels and dense tissue that they hypothesize make it difficult for drugs to permeate. They will use a small animal disease model and patient lung samples to test whether co-treatment with anti-angiogenics and anti-fibrotics can normalize the blood vessels and improve the delivery of anti-tuberculosis drugs thereby increasing their activity and potentially shortening treatment duration.

Lauren Hendricks and team at CARE in Uganda will analyze whether motivating women to use mobile financial technology increases their involvement in making household financial decisions, and subsequently improves family health and education. They will develop mobile money subwallets for specific purposes such as school fees and pregnancy so that women can more securely manage their savings. They will also work with influential members of a subset of households to help promote gender equality and develop a consensus towards a household financial action plan.

Funmilola OlaOlorun of the University of Ibadan in Nigeria and Neetu John of the International Center for Research on Women, in the U.S. will conduct a cluster randomized control trial to evaluate a multi-pronged approach for empowering Nigerian women within the household and thereby the wider community. Their program targets both partners of couples, both individually and together, and involves training on gender socialization and finance, and access to family planning. The aim is to generate rigorous evidence on how to promote gender equality in household decision-making and improve family health and wellbeing.

Laurent Uwumuremyi and team at CARE in Burundi will evaluate the impact of an intensive gender transformative approach among women smallholder farmers relative to a current “gender-light” approach for delivering income, food security and women’s empowerment outcomes through agricultural development interventions. Their transformative approach focuses more deeply on gender by generating awareness of the issues, building personal skills, and directly challenging underlying inequalities through dialogue and collective action involving male relatives and the wider community. They will train facilitators and recruit a total of 7,500 women in two provinces in Burundi for a four-year study. The research will provide essential evidence-based policy recommendations for the agricultural sector to help improve global food security and well-being.

Louis Schofield of James Cook University in Australia will develop a broad-spectrum malaria vaccine that is effective against different life-cycle stages of multiple species of the causative Plasmodium parasite. More than one third of the world's population is at risk of contracting malaria. However developing an effective vaccine is challenging because humans are infected by five quite distinct Plasmodium species. In addition the parasites pass through very different developmental stages including sporozoites which mosquitoes inject into the human bloodstream a disease-causing blood stage and a transmissible sexual stage. Using Grand Challenges Explorations funding they have already identified a surface oligosaccharide antigen conserved in several Plasmodium species that when combined with generic carriers and adjuvants can generate a strong immune response that blocks several life-cycle stages in animal models. They will perform further key preclinical evaluations to determine the full efficacy of the vaccine and whether it should proceed to testing in humans.

Rohini Pande of Harvard University in the U.S. will conduct two large-scale randomized controlled trials (RCTs) which will investigate whether female-friendly modifications to the Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGS) program in India can improve program efficiency and increase rural women's employment, financial inclusion, and empowerment. They will also test the efficacy of transparency tools to document wage payment delays to understanding whether holding local implementers accountable can decrease payment delays to women.

Ross Anderson at the University of Cambridge in the United Kingdom will develop technology to enable secure offline phone-to-phone and card-to-phone payments between customers and merchants. The ability to use mobile phones to make and receive payments has expanded access to secure financial services in low-resource settings. However, the requirement of a network connection makes it particularly problematic in rural communities. They will develop SIM overlay technology, modern cryptography and audio coupling to securely transfer payments offline also from a SIM format payment card for those without a phone. Merchants can then bank the payments periodically whenever they have a network connection. They will evaluate their prototype for usability and security, and work towards interoperability across countries so that migrant workers can also use it.

Ronald Azairwe of Pegasus Technologies Ltd. in Uganda will develop an online portal coupled with attractive incentives to recruit merchants and train them to accept mobile money in Uganda. Current methods of recruitment are slow and require multiple in-person visits, which can be difficult in remote areas. The portal will enable merchants to register online and an incentive structure will be developed to reward merchants based on transaction volume. They will test their portal by advertising to merchants in one urban and one rural location where large numbers of employees receive their salary in mobile money, thereby boosting demand for merchants to accept mobile money. They will also provide an online and phone-based helpline.

Chase Beisel of North Carolina State University in the U.S. will exploit non-lytic bacteriophage for promoting infant gut health and treating enteric infections in low-resource settings. Generally, lytic phage are being studied for treating diseases, but they suffer from a number of limitations including causing resistance and the release of endotoxins, which can damage healthy cells. They will use the CRISPR-Cas9 defense system to engineer non-lytic P1 phage to specifically target the bacteria Shigella sonnei, which is a leading cause of enteric diseases in children in the developing world. The engineered phage, which can be produced at low cost, will be tested for ability to efficiently infect and kill the targeted bacteria.

Flaminia Catteruccia of President and Fellows of Harvard College in the U.S. will produce fabrics and nets treated with the dibenzoylhydrazine (DBH) compound methoxyfenozide, which is toxic to malaria-transmitting mosquitoes, to prevent these insects from entering households and spreading disease. The compound is non-toxic to mammals but disrupts steroid signaling pathways in the mosquito, which is a different mechanism than existing insecticides, reducing lifespan and causing sterility. They will combine it with insecticide and evaluate different formulations on geographically diverse mosquito species in the laboratory. The best formulations will then be tested on specific field-collected outdoor mosquito populations from southern Africa.

Akinola Dixon of Qrios Networks in Nigeria will simplify mobile money payments by building a platform incorporating a unique digital identity for all customer accounts and merchants, and leveraging a stable carrier signaling network using low-cost, automated communication technologies. When a merchant wishes to sell goods, the platform generates a unique payment code for the consumer to authorize on their mobile phone, and the money is transferred. They will research the requirements for their approach, design the required software, and test their platform.

Koen Dechering of TropIQ in The Netherlands will produce an artificial meal for breeding blood-feeding mosquitoes more easily and effectively in the lab. They will develop a high-throughput screening approach using molecular barcodes carried by endosymbiont bacteria that each tag an individual meal consumed by a live mosquito. The barcodes can then be used to identify those meals that best promote egg laying and longevity from a large pool of test foods. They will rationally design the protein and lipid compositions of the test foods for their screen by using mass spectrometry on blood-fed mosquitoes. Optimized diets identified from the screen will be further validated and analyzed for stability also at tropical ambient temperatures.

Alessio Fasano of Massachusetts General Hospital in the U.S. will isolate bacteriophage (viruses that infect bacteria) that specifically kill pathogenic Escherichia coli and Shigella bacteria, which cause environmental enteropathy and other potentially deadly childhood diseases. They will perform a high-throughput screen using a diverse phage library to isolate phage that specifically target the type-III secretion system expressed by enteric pathogens like E. coli. They will also test an alternative approach by constructing phage to carry so-called CRISPR-Cas9 nucleases that they will engineer to target and cleave bacterial type-III secretion system genes. Results from both approaches will be tested for their capacity to selectively kill enteric pathogens and inhibit infection in a human organoid model, which consists of different cell layers to mimic the structure and function of the human gut.

Brian Foy of Colorado State University in the U.S. will use antibodies that bind essential proteins in the mosquito Anopheles in order to block malaria transmission. They have already produced antibodies that bind conserved mosquito antigens such as the glutamate-gated chloride channel and used them to supplement blood meals, which was lethal to feeding mosquitoes. They will test whether cattle injected with these antigens produce the corresponding antibodies that are also lethal to the mosquitoes that feed off them.

Jason Gill of Texas A&M AgriLife Research in the U.S. will develop an animal model for environmental enteropathy, which is a chronic inflammatory condition of the gut prevalent in children from low-income countries, to test new bacteriophage-based treatments. Bacteriophage (phage) are viruses that infect and can kill bacteria, and can therefore be used to treat bacterial diseases. They will develop a chronic disease model by infecting weaned piglets with low doses of enterotoxigenic Escherichia coli, which is likely involved in environmental enteropathy development in humans. They will also search for a combination of different phage types that can infect and destroy this bacterial strain and effectively cure the disease in their animal model.

Margaret McConnell of Harvard University and Mindy Hernandez of Mobiles4All (M4A) in the U.S. will generate rich datasets related to mobile phone use in Africa by providing mobile phones and incentives for users to share data. These datasets are of value to policymakers to promote the use of mobile money. They are collaborating with mobile network operator Vodacom Mozambique, behavioral scientists at Harvard University and developmental experts. They will run a pilot test, offering at-cost smart phones to 5,000 low-income customers in Mozambique, and evaluate the value of offering rewards in exchange for completing phone-based surveys. These surveys will be far quicker and simpler and cost less than traditional population-based surveys. They will combine the survey data with mobile network data, and package the results into a simple dashboard that can inform about mobile money use and how it might be enhanced.

Paula Hidalgo-Sanchis and team at Pulse Lab Kampala – UN Global Pulse in Uganda will develop software that can transform raw data on mobile money use in developing countries into user-friendly formats to inform policymakers and researchers to help expand the field. They will collect mobile money and call detail records from two collaborating network providers, while ensuring privacy of users. In parallel, they will collect complementary datasets such as household survey data to enrich the value of the financial services data. They will process the data to evaluate the relationship between mobile money usage and, for example, geographical location or local economic and environmental factors.

Bastiaan Hoogendoorn at Cardiff University in the United Kingdom will develop a simple, inexpensive breath-testing device to measure the type and levels of bacteria in the lungs for rapid diagnosis of pneumonia in children in low-resource settings. Rather than condensing the exhaled breath, which can cause variation, the device directly captures respiratory fluid droplets containing non-volatile pathogen markers. These markers can then be identified using low-cost commercially available bioassay kits. They will analyze biomarker levels in the breath of sick and healthy children, and test and refine the design of their prototype.

Carina King of the Institute for Global Health in the United Kingdom will use bioelectric impedance vector analysis (BIVA) to measure nutritional status in children with pneumonia in Malawi in order to improve treatment. Malnutrition is strongly associated with poor prognosis in pneumonia but is difficult to accurately assess. BIVA measures bioelectric properties to predict physiological parameters such as hydration and body mass of specific body regions. They will develop a protocol and evaluate BIVA for assessing nutritional status in children with pneumonia compared to current assessment methods. They will also lead focal discussion groups to evaluate related knowledge and likely acceptance of the protocol by health workers and care staff. Finally they will conduct a pilot training program on the technology for health care workers.

Chris Locke of Caribou Digital (UK) Ltd. in the United Kingdom will develop a small set of applications for smart phone users in developing countries to put them in control of providing anonymous data on their mobile phone use in near real-time to aid analysis and research by donors and governments. The applications will be able to record digital financial transactions and other phone-based activities such as content browsing to provide additional context and thereby enrich the data. They will develop the software for testing on a panel of users in Kenya, and collect and analyze the data.

Joanne Macdonald from the University of the Sunshine Coast in Australia will develop a simple diagnostic test that can be used in the field to rapidly identify mosquitoes infected with pathogens such as the malaria parasite and dengue virus. Traditional methods require costly equipment and a laboratory setting. The test combines recombinase polymerase amplification (RPA) with a lateral flow strip and can detect DNA from multiple pathogens in parallel, which will reduce costs. They will first perform a proof-of-concept study using laboratory-infected mosquitoes to evaluate the test and develop smart-phone software to translate the results. They will then perform field trials in Cairns to evaluate if their test can detect single infected mosquitoes placed in field traps containing uninfected insects.

Szabolcs Marka of Columbia University in the U.S. will develop acoustic software to locate mosquito swarms by their sound, thereby allowing elimination of thousands of breeding vector mosquitos that can cause diseases such as malaria. They have already demonstrated that they can acoustically detect a single distant mosquito in a noisy laboratory setting. They will further develop acoustic locator hardware and sensors targeting the common malaria mosquito Anopheles and field-test its performance in locating swarms from several tens of meters. By studying the acoustics of single mosquitoes as well as of swarms, it could be possible to track the behavior of individuals and to artificially induce swarm formation, to further support disease control efforts.

Grant McKenzie of Spatial Development International in the U.S. will map the location of activities (touch points) related to financial services in developing countries by geosocial data mining, analysis and modeling to increase the efficiency and reduce the cost of data collection. They will first evaluate whether social media platforms such as Facebook, which include some geographic information, can be used to identify the location of actual touch point locations and from that develop a spatial regression model for estimating distribution in an unmapped, developing country. They will also develop a data collection platform that displays point of interest data for users to supplement with photographs and text, and add any unmapped touch points. In this way, unmapped regions can be easily identified for further exploration. They will evaluate the platform by surveying its performance in a test country.

Johanna Ohm of Pennsylvania State University in the U.S. will produce an insect-based diet for breeding adult malaria-transmitting Aedes and Anopheles mosquitoes in the laboratory. Laboratory mosquitoes are most effectively bred for research using mammalian blood meals, which has numerous limitations including higher costs and requiring human volunteers with stringent regulations. It is known that some mosquitoes can produce viable eggs after feeding on soft-bodied insect larvae such as lepidopteran larvae. They will screen a selection of larvae to identify the most palatable insect-based diets, and evaluate them for effect on mosquito survival, fecundity and offspring viability compared to mosquitoes reared on blood-based diets.

Frederic Pivetta of Real Impact Analytics in Luxembourg will develop a platform and applications to leverage data from telecom operators to identify individuals in developing countries, who are often women, without access to digital financial services. They hypothesize that these isolated individuals display unique cell phone behaviors that they can use to identify them. Once identified, they can be directly targeted with appropriate campaigns and products to encourage them to get beneficial financial services such as mobile money accounts. They will refine a predictive model to identify selected user features such as calling volume and social network characteristics from large datasets.

Ernesto Damiani of Khalifa University in the United Arab Emirates will develop a software toolkit to enable the secure purchase of goods by taking a photo with a simple mobile phone. The procedure only requires both purchaser and merchant to carry a simple phone and to visually identify themselves and details of the purchase, for example with a card, that can be captured in a single photograph. They will build software that uses visual cryptography to divide the photograph into two parts or shares, one sent to each phone. When a network connection is encountered, the shares are transmitted to a third party who runs a point-of-service and reconstructs the image thereby validating the transaction before transferring payment. This method enables transactions between individuals in low network connectivity areas and by illiterate parties.

Haiqing Sheng and collaborators Carolyn Bohach and Scott Minnich from the University of Idaho in the U.S. will exploit the CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated protein 9) system in a dual approach to combat enteropathogenic Escherichia coli (EPEC) infections. EPEC cause diarrhea and result in several hundred thousand infant deaths annually. They will engineer a CRISPR-Cas9 cassette to recognize and cleave a DNA sequence found specifically in EPEC, which will lead to selective EPEC cell death in the intestinal tract without affecting other beneficial bacteria. The engineered CRISPR-Cas9 will be administered using both safe EPEC-targeting viruses (bacteriophage) to treat primary infections as well as probiotic E.coli to stably establish the EPEC-targeting plasmid in the gut and block re-infection. They will test it using an established rabbit model of EPEC infection, which will pave the way for future clinical testing.

Brandyce St. Laurent of the National Institutes of Health in the U.S. will test whether cow-baited tents can be used to monitor and control disease-causing mosquitoes in the Greater Mekong Subregion. Most Anopheles mosquitoes preferentially bite animals, but they still contribute to malaria transmission in humans, and many bite outdoors, rendering bednets and indoor repellants useless against them. They will produce low-cost tents treated with insecticide, and locally rent cows as bait. The tents will be set up in both villages and forests and the captured mosquitoes will be analyzed to evaluate the efficacy of their approach.

Jessica Vernon and Jennifer Stutsman of Maisha Meds in Kenya will encourage chemists and pharmacies to accept mobile money in East Africa by integrating their tailored software application with an established mobile payment system, and providing automatic registration and financial incentives. Chemists have found it particularly difficult to track transactions made using mobile money and therefore tend to avoid using it. Their existing software program can be run on locally available tablets and enables digital recording of pharmacy's sales and purchases, and stock tracking. They will integrate this with a mobile payment system and offer it to a network of chemists who use mobile money to evaluate the effect on frequency of mobile money transactions. They will also test whether automatic registration to a mobile payment system along with access to competitive loans can sign-up more chemists than existing subscription packages.

Lynne Thomson of TNS Global Research in the U.S. will use SMS to track digital and non-digital financial transactions in near real time to inform development agendas and boost uptake. Digital financial services help the poor lift themselves out of poverty, but measuring uptake is currently slow and expensive. SMS is widely used throughout Sub-Saharan Africa, and they will perform a proof-of-concept study in Kenya using SMS to send short surveys to a group of users to extract basic information on their recent financial transactions, such as type, date, and amount. They will develop a statistical approach to model the data and track behavior over time.

Baojun Wang of the University of Edinburgh in the United Kingdom will engineer bacteriophages to selectively target gut pathogens such as Shigella and Salmonella that cause widespread environmental enteropathy in infants in developing countries. They will program the CRISPR-Cas9 (clustered, regularly interspaced short palindromic repeats–CRISPR-associated proteins) nucleases to cut the chromosomes of the target pathogens, and test their ability to block infection in a mouse gut colonization model while leaving the non-pathogenic and often beneficial bacteria largely intact.

Dawn Wesson and Sam Jameson of Tulane University in the U.S. will develop an artificial meal for mosquitoes based on algae as a protein source that can be freeze dried and stored in blister packs, and refine their reusable feeding system. Mosquitoes are currently laboratory reared using expensive and difficult to obtain mammalian blood to ensure adequate numbers of offspring for studying. They proposed that a spirulina (Arthrospira platensis) would be an ideal candidate for feeding mosquitoes due to it being a complex protein source, easy to mass produce, and dark in color, which is a feeding cue for mosquitoes. They will supplement it with insect juvenile hormone, which stimulates egg production, sugar and salt, and test its palatability and effect on egg production in a number of different mosquito species using iterations of their meal delivery system compared to human blood.

Christine Yee with Darpan Bohara and Yashna Sureka of Smith College in the U.S. will develop a fingerprint scanner that can link to phone networks and banks to enable merchants to easily and quickly accept mobile money payments in India. Fingerprint identification is relatively secure and will simplify the payment process so people with different levels of literacy can use it. They will test their prototype by giving deposits to a group of students and scanners to local merchants in Nelamangala, India, and providing the associated knowledge and resources needed to use their mobile money transfer system.

Mirko Zimic of Universidad Peruana Cayetano Heredia in Peru will develop a simple, low-cost lung ultrasound device that can automatically diagnose bacterial pneumonia and measure nutritional status in children in low-resource settings. They have developed an algorithm to detect lung infiltrates from digital ultrasound images as evidence of pneumonia in children, and have built a prototype device, which comprises an ultrasound probe connected to a laptop or smartphone for realtime analysis of the images. Visible and audio alerts are used to notify the technician of suspect regions. They will develop an additional algorithm to automatically measure anatomical parameters including rib diameter and skin thickness for predicting levels of malnutrition, and test it in a hospital in Peru. Ultimately, this will be incorporated into the ultrasound device so that both pneumonia and malnutrition can be easily diagnosed together by non-specialized health care workers.

Neil Patel of AwaazDe Infosystems Pvt Ltd in India will produce interactive podcasts that are sent by mobile phone to inform local users in India on relevant financial services and to collect their feedback on specific issues in audio form, making it more widely accessible. The feedback will be used to monitor financial habits, and help identify barriers to usage and ways to improve services. The interactive podcast platform can also be supplemented with optional features such as balance inquiries or loan repayment reminders. AwaazDe (“give voice”) will tailor the technology, and work with partners to pilot test the podcasts and collect data first in 10 villages in India, followed by scaling up to 50,000 users.

Kathleen Colson of The BOMA Project, Inc. in Kenya will investigate, measure and document how participation in BOMA’s Rural Entrepreneur Access Project (REAP)—a holistic two-year program of sequenced interventions—translates to such gender-influenced outcomes as increased household financial decision-making by women, increased education opportunities for girls and increased food security and use of healthcare by the household. REAP is a high-impact poverty graduation program that addresses the geographic and socio-economic context of the arid and semi-arid lands of Africa, where the harsh effects of climate change and endemic extreme poverty persistently undermine the well-being of women and children. The project provides ultra-poor Kenyan women cash grants, business skills training, mentoring and the opportunity to set up their own business to help lift their families out of poverty. Giving women more power over household spending tends to lead to improved family health care and education. They will recruit 750 women living in extreme poverty in pastoral communities to their two-year poverty graduation program. Upon these women exiting REAP, they will analyze its impact on improving the education and social standing of women and girls, and the physical and financial wellbeing of their families.

Maria do Carmo Leal from Fiocruz in Brazil will undertake a pilot “Parto Adequado” (Adequate Birth) project to evaluate whether different health care models offered by medical institutions during pregnancy and childbirth can promote healthier births, particularly by reducing the rate of unnecessary medical procedures. These include caesarean section without clinical indication, which occur frequently in Brazil and can have negative consequences. They have selected 23 geographically dispersed hospitals for the pilot study, which will involve around 16,000 mothers. To promote good practices, they have developed three health care models that combine different numbers and types of medical staff (i.e., Doctors and nurses-midwives) to be involved at specific stages from pregnancy to birth. These will be offered to hospitals for implementation over 18 months. They will then analyse the degree of implementation of the models, and their effects on the type of birth, adoption of good practices, and hospital costs after two and three years. They will also interview the mothers and health care workers to evaluate acceptability of the different models.

Sonia Isoyama Venancio from the Instituto de Saúde in Brazil will implement a program for monitoring the development of children less than five years of age during vaccination campaigns in the municipalities, to help identify risk factors, raise awareness, and support healthy development. They will design and pilot test a questionnaire that can be easily applied during a vaccination procedure to carefully query the health and behavior of the child, as well as their family environment and access to health services and education. To promote implementation of the program, they will recruit and train interviewers, and partner with Universities to recruit health-care students for collecting the data and entering them into a custom built web application. They will validate their approach for identifying children with developmental problems, and analyze the data for potential causes such as socioeconomic conditions and quality of health care.

Rita de Cássia Silveira from Hospital de Clínicas de Porto Alegre in Brazil will develop and test a program for families with preterm infants to follow at home to improve the child’s cognitive, motor and social development. Preterm infants (those born with less than 37 weeks of gestation) can suffer a variety of complications due to incomplete brain, lung and eye development, which can cause long-term problems. They have shown that careful baby massage, alongside the standard skin-to-skin care by the mother, in the hospital after birth can improve the child’s neurological development at two years of age. Here they will perform a randomized study of around 80 mothers of preterm infants, and teach one group to perform the massage technique and instruct them to administer it at home for the child’s first 12 months of life, which will be carefully monitored. The effects on motor and neurodevelopment will be assessed at regular intervals up to 24 months of age and compared to a control group performing only skin-to-skin care.

Mauricio Lima Barreto from Fiocruz in Brazil will evaluate the impact of social and economic inequalities, and the national family allowance program (Bolsa Familia), on healthy births and early childhood health and development. They will setup a cohort, which will be derived from a central database of named households created to support Brazil’s social programs, and a data center for the analysis. They will use a variety of demographic, economic and social data on families, as well as information on births and childhood deaths, and child growth. The impact of receiving family allowance, and the effect of its value and duration, on outcomes such as birth weight, prematurity, fetal death, and early childhood growth will also be measured. This approach will generate evidence to help maximize the value of the social program and inform future related policies.

Maria Conceicao do Rosário from Universidade Federal de São Paulo in Brazil will assess the effect of mother and teacher support programs in pre-schools in poor districts of São Paulo on the physical and emotional well-being of families, and on early childhood development. Many poor communities in Brazil suffer from high levels of urban violence and adult mental illness that affect the healthy development and well-being of children. Brazil has pledged that all children aged 4-6 will be in pre-school by 2016, presenting an opportunity to improve the quality of pre-school teaching to impact childhood development. They will recruit around 900 mothers to evaluate a mother support program, which will involve weekly group meetings for around 12 weeks to discuss issues including parenting methods and healthy child development. They will also implement a teacher support program to increase their knowledge on childhood health and development, and assess the impact on their attitudes and practices.

In collaboration with the Rwandan Ministry of Health National Research Laboratory, and our on the ground implementing partners, Nanobiosym will reduce HIV related deaths in infants by scaling up access to its novel POC nanodiagnostic platform by validating Nanobiosym's proprietary Point-of-Care Gene-RADAR diagnostic platform's ability to measure HIV positive mothers' viral load thereby ensuring they are responding to ART and reducing their chances of transmitting HIV to their child in-utero, at birth, or during the breastfeeding period.

Diagnostics For All will develop a sensitive, low-cost, rapid, paper-based microfluidic diagnostic test to screen pregnant women for anemia, HIV, HBV, and syphilis, from one drop of blood. This antenatal care (ANC) test panel will ensure that women who attend ANC at least once are tested for the most critical diseases and provided results on the spot. This ANC panel could improve maternal and child health outcomes for up to 31 million pregnant women in the developing world and their children.

Our idea is to develop BiliSpec, a bilirubin monitoring device with a per-test cost of less than $0.10. BiliSpec includes: (1) a lateral-flow device to separate serum from whole blood in under 30 seconds and (2) a battery powered reader to measure light transmission through the separated serum on the strip and display the bilirubin concentration. We estimate our device could prevent the deaths of approximately ninety-thousand neonates who die every year due to lack of access to effective treatment and monitoring for neonatal jaundice in low-resource settings.

In collaboration with the Rwandan Ministry of Health & National Research Laboratory, and our on the ground implementing partners, Nanobiosym will reduce HIV related deaths in infants by scaling up access to its novel POC nanodiagnostic platform by validating Nanobiosym's proprietary Point-of-Care Gene-RADAR® diagnostic platform's ability to measure HIV positive mothers' viral load thereby ensuring they are responding to ART and reducing their chances of transmitting HIV to their child in-utero, at birth, or during the breastfeeding period.

Bioceptive aims to expand access to long-acting reversible contraception (LARC) for the estimated 222 million women around the world with an unmet need for modern family planning resources. The discreet intrauterine device (IUD) is one of the most applicable LARC methods for global use due to its long term of use, high efficacy, and minimal user effort. However, IUD access is frequently limited because the insertion procedure is complicated and only carried out by highly trained physicians. Bioceptive has developed a novel, reusable, sterilizable IUD inserter that makes the procedure simpler and intuitive and allows any healthcare worker to confidently insert an IUD with minimal training, thus using improved technology to overcome existing barriers to service delivery.